Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis

Clinical and Experimental Immunology

Volumn 166, Issue 2, 2011, Pages 235-250

  Watanabe, T ^a   Kanamaru, Y ^a   Liu, C ^a   Suzuki, Y ^a   Tada, N ^b   Okumura, K ^b   Horikoshi, S ^a   Tomino, Y ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Animal models studies mice rats; Antibody responses; Fc receptors(FcRs); Renal immunology disease; Signalling signal transduction

Indexed keywords

CHIMERIC PROTEIN; I KAPPA B; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 9;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSFER; CONTROLLED STUDY; GLOMERULONEPHRITIS; GLOMERULUS; IMMUNE RESPONSE; IMMUNOGLOBULIN DEPOSITION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLOMERULONEPHRITIS; HUMANS; IMMUNOGLOBULIN A; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY; KIDNEY GLOMERULUS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN TYROSINE PHOSPHATASES; RECEPTORS, FC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 80053649346     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04452.x     Document Type: Article

References (36)

1. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998; 280:243-8.
2. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000; 290:84-9.
3. Burshtyn DN, Lam AS, Weston M, Gupta N, Warmerdam PA, Long EO. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors. J Immunol 1997; 162:897-902.
4. Pfefferkorn LC, Yeaman GR. Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2. J Immunol 1994; 153:3228-36.
5. Launay P, Patry C, Lehuen A, Pasquier B, Blank U, Monteiro RC. Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRgamma association and protects against degradation of bound ligand. J Biol Chem 1999; 274:7216-25.
6. Pasquier B, Launay P, Kanamaru Y etal. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005; 22:31-42.
7. Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006; 177:2051-5.
8. Wang L, Gordon RA, Huynh L etal. Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity 2010; 32:518-30.
9. Kobayashi K, Hernandez LZ, Galan JE, Janeway Jr. CA, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110:191-202.
10. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335-76.
11. Hemmi H, Takeuchi O, Kawai T etal. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5.
12. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20:709-60.
13. Yeo SJ, Yoon JG, Yi AK. Myeloid differentiation factor 88-dependent post-transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: tumor necrosis factor-alpha receptor-associated factor 6, a diverging point in the Toll-like receptor 9-signaling. J Biol Chem 2003; 278:40590-600.
14. Iskandar SS, Jennette JC. Influence of antibody avidity on glomerular immune complex localization. Am J Pathol 1983; 112:155-9.
15. Anders HJ, Frink M, Linde Y etal. CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 2003; 170:5658-66.
16. Kanamaru Y, Pfirsch S, Aloulou M etal. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation. J Immunol 2008; 180:2669-78.
17. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26:137-43.
18. Sato M, Watanabe T, Oshida A, Nagashima A, Miyazaki JI, Kimura M. Usefulness of double gene construct for rapid identification of transgenic mice exhibiting tissue-specific gene expression. Mol Reprod Dev 2001; 60:446-56.
19. Anders HJ, Banas B, Linde Y etal. Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol 2003; 14:317-26.
20. Ravindran C, Cheng YC, Liang SM. CpG-ODNs induces up-regulated expression of chemokine CCL9 in mouse macrophages and microglia. Cell Immunol 2010; 260:113-18.
21. Launay P, Grossetete B, Arcos-Fajardo M etal. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 2000; 191:1999-2009.
22. Kazimierczak K, Kopec W, Klinger M. Toll-like receptors (TLR) in the pathogenesis of kidney diseases. Pol Merkur Lekarski 2007; 23:382-5.
23. Ho AW, Wong CK, Lam CW. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways. Immunobiology 2008; 213:533-44.
24. Stambe C, Atkins RC, Tesch GH etal. Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol 2003; 14:33851.
25. Wu P, Wu J, Liu S etal. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Clin Immunol 2008; 129:40-8.
26. Hornung V, Schlender J, Guenthner-Biller M etal. Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J Immunol 2004; 173:5935-43.
27. Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production. J Leukoc Biol 2009; 86:261-71.
28. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 2005; 23:901-44.
29. Phan T, Grigorova I, Okada T, Cyster J. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol 2007; 8:992-1000.
30. Bergtold A, Desai DD, Gavhane A, Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 2005; 23:503-14.
31. Koppel EA, Wieland CW, van den Berg VC etal. Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection. Eur J Immunol 2005; 35:2962-9.
32. Kanamaru Y, Tamouza H, Pfirsch S etal. IgA Fc receptor I signals apoptosis through the FcRgamma ITAM and affects tumor growth. Blood 2007; 109:203-11.
33. Bartoe JL, Nathanson NM. Differential regulation of leukemia inhibitory factor-stimulated neuronal gene expression by protein phosphatases SHP-1 and SHP-2 through mitogen-activated protein kinase-dependent and -independent pathways. J Neurochem 2000; 74:202132.
34. Lee K, Esselman WJ. Inhibition of PTPs by H(2)O(2) regulates the activation of distinct MAPK pathways. Free Radic Biol Med 2002; 33:1121-32.
35. Song M, Park JE, Park SG etal. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26). Biochem Biophys Res Commun 2009; 381:491-5.
36. Smith RE, Patel V, Seatter SD etal. A novel MyD-1 (SIRP-1alpha) signaling pathway that inhibits LPS-induced TNFalpha production by monocytes. Blood 2003; 102:2532-40.